Alicia McElhaney

Recent Articles By The Author

Biotech Movers: Cempra Flys High On Phase Three Results

Biotech Movers: Cempra Flys High On Phase Three Results

Other movers include Incyte, Achillion and Inovio.

Argos Plummets 72%, Leads Biotech Movers

Argos Plummets 72%, Leads Biotech Movers

Also falling was Global Blood Therapeutics.

Valeant Acquires Eyegate Licensing Rights

Valeant Acquires Eyegate Licensing Rights

The company paid $4 million up front for the licensing rights for Eyegate's drop device.

Medtronic Earnings Rebound in Third Quarter, Shares Climb

Medtronic Earnings Rebound in Third Quarter, Shares Climb

The company discusses potential share repurchases and its acquisition strategy.

Sarepta Leads Biotech Movers on Voucher Deal News

Sarepta Leads Biotech Movers on Voucher Deal News

Gilead (finally!) has acquired something from Sarepta, even if it is quite small.

Aetna Shares Bounce Back After Close

Aetna Shares Bounce Back After Close

Healthcare giant Aetna announced a share buyback program Friday.

Clovis, Tesaro Soar on Astrazeneca Phase Three News

Clovis, Tesaro Soar on Astrazeneca Phase Three News

AstraZeneca shares, meanwhile, were less-than-moved by the news.

United Healthcare Whistleblower Suit Provides 'Interesting' Investment Opportunity

United Healthcare Whistleblower Suit Provides 'Interesting' Investment Opportunity

Analysts say the stock depression caused by a lawsuit filed by a former United Healthcare executive could be a reason to buy the stock.

Sage Therapeutics Leads Biotech Movers on False Takeout Rumors

Sage Therapeutics Leads Biotech Movers on False Takeout Rumors

In addition to Sage Therapeutics, also moving biotech Friday: Novavax, Cytokinetics and Acadia Pharmaceuticals.

Zoetis Reports Earnings Beat, So Why Are Shares Plummeting?

Zoetis Reports Earnings Beat, So Why Are Shares Plummeting?

The New Jersey-based animal health company reported better-than-expected fourth quarter earnings Thursday, but shares fell 5%.